Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
6-K
Operational Other
confidence 85%
filed 2026-09-01
EX-99.1
Telix announced completion of enrollment in the Phase 3 BiPASS study (350 patients) and alignment with the FDA on an NDA pathway for its PSMA-PET imaging agents (Illuccix and Gozellix). This is a material clinical and regulatory milestone—successful completion of a pivotal registrational trial and FDA pathway alignment—that advances the company's product pipeline and could expand market access. The event is operational/strategic (clinical trial progress and regulatory engagement) rather than a discrete financial, governance, or legal event, and does not fit the earnings_release, ma_activity, or other specific categories.
View raw filing on EDGAR →
8-K
Financial Other
confidence 75%
filed 2026-09-01
Item 8.01
Lexaria received an Australian R&D tax credit of AUD$3.67M (USD$2.6M) from the Australian Tax Office for research and development costs associated with its clinical study GLP-1-H24-4. This is a material financial event—a non-operating credit that increases cash available for operations—but does not fit the specific financial categories (debt issuance, dividend distribution, impairment, restatement, etc.). The credit is clearly financial in nature and material to a reasonable investor assessing the company's liquidity and funding for R&D activities.
View raw filing on EDGAR →
8-K
Cybersecurity Incident
confidence 95%
filed 2026-09-01
Item 8.01
NovoCure disclosed unauthorized access to its information systems in mid-August 2026 affecting over 1,400 U.S. patient records with internal patient ID numbers and fewer than 50 additional patient records with identifying information, plus healthcare provider and employee contact data. Although the Company states it does not currently believe the incident will have material financial impact, the disclosure of a cybersecurity breach involving patient data is itself material to investors under Item 1.05 (required since 2023) and affects the total mix of information available regarding operational risk, regulatory compliance, and potential liability exposure.
View raw filing on EDGAR →
6-K
Dividend Distribution
confidence 95%
filed 2026-09-01
EX-99.1
Ferrari announces completion of the second tranche and initiation of the third tranche of a multi-year share repurchase program totaling approximately €3.5 billion through 2030. The disclosure reports €199.9 million in shares repurchased on EXM and $58.0 million on NYSE in the second tranche, with a third tranche of up to €250 million commencing September 2, 2026. Share repurchase programs constitute a return of capital to shareholders and fall within the dividend_distribution category as defined in the taxonomy.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-09-01
Item 8.01
BayFirst Financial Corp. announced commencement of a rights offering to existing shareholders, offering up to 4,108,072 shares of common stock at $3.50 per share. The press release explicitly states the SEC issued a Notice of Effectiveness for the Form S-1 Registration on August 31, 2026, and the final prospectus was filed pursuant to Rule 424(b)(3). This is a material equity issuance that will dilute existing shareholders and is part of the company's "recapitalization," signaling capital-raising activity typical of dilutive issuances.
View raw filing on EDGAR →
6-K
Earnings release
confidence 75%
filed 2026-09-01
This 6-K furnishes a press release announcing positive Phase III trial results for Tagrisso plus Orpathys in first-line EGFRm lung cancer (SANOVO trial). The disclosure reports statistically significant and clinically meaningful improvement in progression-free survival, a key efficacy endpoint. While technically a clinical trial result rather than financial earnings, this is material to investors as it represents a significant clinical milestone for a major oncology combination therapy that could expand market opportunity and support future revenue growth for AstraZeneca's lung cancer franchise.
View raw filing on EDGAR →
6-K
M&A activity
confidence 95%
filed 2026-09-01
AstraZeneca announced the completion of an exclusive license agreement with Dizal Pharmaceutical to acquire worldwide rights to develop and commercialize Zegfrovy (sunvozertinib), an oral EGFR inhibitor for lung cancer. The transaction involves an upfront payment of $600 million plus up to $900 million in milestone payments, representing a material acquisition of intellectual property and commercial rights that would affect investor assessment of the company's oncology portfolio and capital deployment.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-09-01
AstraZeneca announced the appointment of Wan Ling Martello as a Non-Executive Director effective 1 September 2026, with membership on the Audit Committee. This is a clear executive appointment to the board of a major pharmaceutical company, and the disclosure includes biographical details and a statement from the Chair endorsing her qualifications. Board appointments at large-cap public companies are material to investors assessing governance and oversight.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-09-01
This 6-K discloses European Commission approval of Enhertu (trastuzumab deruxtecan) in combination with pertuzumab for first-line treatment of HER2-positive metastatic breast cancer, based on positive Phase III DESTINY-Breast09 trial results showing 44% reduction in disease progression or death risk. While this is a regulatory/product milestone rather than a discrete financial event, M&A activity, or governance matter, it is material to investors as it represents a significant commercial expansion of a key oncology asset with substantial market potential, supported by a $100 million milestone payment from AstraZeneca to Daiichi Sankyo. The event is operational in nature—a regulatory approval and product launch milestone—rather than fitting the specific categories of earnings, M&A, or financial obligations.
View raw filing on EDGAR →
6-K
Debt Issuance
confidence 95%
filed 2026-09-01
AstraZeneca announces admission to trading of €2.55 billion in debt securities across four series (€700M, €600M, €500M, and €750M notes) with maturities ranging from 2030 to 2038, issued by its wholly owned subsidiary AstraZeneca Finance LLC and admitted to the London Stock Exchange Main Market on 1 September 2026. This constitutes creation of a material direct financial obligation and is a significant capital-raising event.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-09-01
GSK announced positive Phase II data for its mRNA seasonal flu vaccine candidate and disclosed advancement to Phase III trials starting September 2026. This is a material operational/clinical milestone in a significant vaccine development program, reflecting progress in GSK's respiratory vaccines research. The disclosure includes FDA Fast Track designation and comparative immunogenicity data versus licensed vaccines, which would affect a reasonable investor's assessment of GSK's pipeline and competitive position in vaccines.
View raw filing on EDGAR →
6-K
M&A activity
confidence 92%
filed 2026-09-01
Vodafone announces that Societe Generale S.A. will acquire a 50% shareholding in OXG Glasfaser Beteiligungs-GmbH, Vodafone's fibre joint venture in Germany. This is a material change in ownership and control of a significant subsidiary asset, securing committed funding for continued network expansion. The transaction constitutes a disposition of a material interest in a joint venture and entry into a new shareholder arrangement, fitting the definition of M&A activity under Item 1.01/2.01.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 95%
filed 2026-09-01
Item 8.01
The filing discloses that Beyond Meat received a deficiency letter on March 4, 2026 for failing to maintain the Nasdaq minimum bid price requirement of $1.00 per share, was given 180 days to regain compliance, and subsequently regained compliance on August 28, 2026. This is a classic delisting-risk disclosure under Item 8.01 — the company faced a material threat of delisting but has now cured the deficiency. The explicit reference to Nasdaq Listing Rule 5450(a)(1) and the compliance determination confirms this classification.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 75%
filed 2026-09-01
Item 1.01
Valion Bio entered into a Letter Agreement on August 31, 2026, whereby 3i purchased 100 Series B Preferred Shares, 7,637 Series C Preferred Shares, and warrants to purchase 1,057,046 shares of Common Stock for $7.737 million under Section 4(a)(2) exemption.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-09-01
Item 5.02
Lisa Wolf was appointed to the expanded roles of President and Chief Operating Officer in addition to her existing Chief Financial Officer role, and Jared Malbin and Thomas Jensen were appointed as directors to the Board, effective August 27, 2026, following the departure of former CEO Michael K. Handley.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 85%
filed 2026-09-01
Item 2.03
Applied Optoelectronics created a direct financial obligation, disclosed via Item 2.03 with incorporation by reference to Item 1.01, affecting the registrant's capital structure and financial position.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-09-01
Item 3.02
The filing discloses an unregistered private placement of 207,848 shares of Series A Convertible Preferred Stock under Regulation D Rule 506(b), generating $2,052,000 in aggregate proceeds during August 2026. This is a classic dilutive equity issuance to accredited investors exempt from registration, with 13.3 million shares of the preferred stock now outstanding as of the filing date. The material capital raise and equity dilution would affect a reasonable investor's assessment of the company's capitalization and ownership structure.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-09-01
Item 7.01
The disclosure announces completion of the last patient visit for a Phase 1 clinical trial of prula-cel in SLE patients, with topline results expected in September 2026, along with updates on FDA clearance of an IND for ADI-212 and advancement of an in vivo CAR-T platform. These are material clinical and regulatory milestones for a clinical-stage biotech company, but do not fit neatly into earnings, M&A, impairment, or other specific event categories. The event is clearly operational/strategic in nature—clinical trial progress and pipeline advancement—making operational_other the most appropriate classification.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-09-01
EX-99.1
The exhibit discloses detailed voting results from First Phosphate's Annual General and Special Meeting of Shareholders held on August 28, 2026, including election of five board directors (John Passalacqua, Laurence W. Zeifman, Bennett Kurtz, Peter Nicholson, and Peter Kent), approval of auditor appointment (Davidson & Company LLP), adoption of an advance notice policy, and re-approval of the omnibus equity incentive plan. This is a classic shareholder_vote_results disclosure under Item 5.07 equivalent, with specific vote tallies and percentages for each matter.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-09-01
EX-99.1
NuRAN announces a strategic expansion of its business model from Network-as-a-Service to Infrastructure-as-a-Service by adding modular edge compute nodes and AI capabilities at its 5,000+ existing rural sites in Africa. This represents a material operational and strategic pivot in the company's service offerings and revenue monetization strategy, though it is announced as a plan and pilot initiative rather than a completed transaction or discrete event. The disclosure does not fit the specific operational categories (no M&A, workforce reduction, or material contract announcement with defined terms), making operational_other the most appropriate classification.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-09-01
EX-99.1
Scorpio Gold announces commencement of trading of its American Depositary Shares (ADSs) on the NASDAQ Capital Market under ticker "SGLD" effective September 1, 2026. This is a material operational and capital-markets event — a new listing on a major U.S. exchange that expands the company's trading venues and accessibility to U.S. investors. While not a discrete M&A, financing, or governance action, the NASDAQ listing is a significant strategic milestone that would affect a reasonable investor's assessment of liquidity and market access. The disclosure includes details on the ADS program, conversion mechanics, and fee structure, confirming this is the announcement of the listing itself, not a routine administrative notice.
View raw filing on EDGAR →
6-K
Delisting risk
confidence 95%
filed 2026-09-01
EX-99.1
The press release announces NuRAN Wireless's application for voluntary delisting from the Canadian Securities Exchange (CSE), with September 4, 2026 expected as the final trading day on that exchange. While the company states this is a voluntary action to consolidate trading on NASDAQ and reduce dual-listing costs, the delisting itself is a material change in listing status that affects investor access and trading venues. The disclosure also includes a director resignation (Navindran Naidoo), but the primary event disclosed is the delisting action.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 95%
filed 2026-09-01
Item 3.01
IP Strategy Holdings received a Nasdaq notification on August 26, 2026, for failure to timely file its Form 10-Q for the period ended June 30, 2026, placing it in non-compliance with Nasdaq Listing Rule 5250(c)(1). The filing explicitly states that "if the Company fails to timely regain compliance with the Listing Rule 5250(c)(1), the Company's common stock will be subject to delisting from Nasdaq." This is a classic delisting-risk disclosure under Item 3.01, with a 60-day cure period ending October 26, 2026, and potential 180-day extension to February 22, 2027.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-09-01
Item 1.01
Root, Inc. entered into a Warrant Cancellation and Exchange Agreement with Carvana on August 31, 2026, whereby Carvana surrendered all outstanding long-term warrants issued in October 2021 and received a new warrant exercisable for up to 1,525,560 shares of Class A Common Stock. The transaction includes simultaneous amendments to the Commercial Agreement, Investment Agreement, and Registration Rights Agreement, constituting a material modification of the capital structure and strategic relationship between the parties.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 75%
filed 2026-09-01
Item 8.01
DeFi Development Corp. announced a proposed initial public offering of up to $20 million of Variable Rate Series C Perpetual Preferred Stock ("CHAD Stock") with a 13.00% annual dividend rate and perpetual maturity. While technically a preferred equity issuance rather than debt, perpetual preferred stock with mandatory cumulative dividends functions economically as a direct financial obligation similar to debt. The filing discloses creation of a new capital instrument with fixed payment obligations, which aligns with the debt_issuance category's scope of "creation of a new direct financial obligation." This is material to investors as it represents a significant capital raise and new recurring dividend obligation.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-09-01
Item 1.02
The filing discloses termination of a material merger agreement dated October 3, 2025, between Quantumsphere Acquisition Corp and SACH Pte. Ltd. The Purchaser Parties delivered termination notice on September 1, 2026, pursuant to Section 13.2(a) of the Merger Agreement, following a thirty-day cure period that expired without resolution. This is a material M&A event—the termination of a previously announced merger—that materially affects the registrant's strategic position and investor expectations, particularly for a SPAC whose primary purpose is to effect a business combination.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-09-01
Item 5.02
The Board appointed Stephan May as a director effective August 27, 2026, and appointed him to the Compensation and Human Resources Committee. The appointment is material as it involves a director-level position designated by major shareholder Siemens Industry under a Stockholders Agreement and fills a vacancy created by a prior resignation.
View raw filing on EDGAR →
8-K
Governance Other
confidence 75%
filed 2026-09-01
Item 6.02
This Item 6.02 discloses a change of servicer in a CMBS trust: Greystone Servicing Company LLC has sold substantially all of its special servicing assets to C-IV Asset Management LLC, effective September 1, 2026, with C-IV AM assuming all duties and responsibilities as special servicer. While the taxonomy includes no dedicated "servicer_change" category, this is a governance-level change affecting the trust's operational structure and the party responsible for managing problem loans and certificateholder interests. The disclosure is material because it affects the identity and qualifications of the entity managing special servicing duties for a $20.7 billion portfolio.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-09-01
Item 6.02
This Item 6.02 discloses a change of servicer in a CMBS trust: Greystone Servicing Company LLC sold substantially all assets of its special servicing division to C-IV Asset Management LLC on September 1, 2026, with C-IV AM assuming all duties and liabilities as special servicer for approximately 60 transactions representing $20.7 billion in aggregate principal balance. While the filing provides extensive operational and financial details about C-IV AM's qualifications and track record, the core event is a change in the party responsible for governance and administration of the securitized loan portfolio. This is material to certificateholders as it affects who manages problem loans and workout strategies, but it does not fit the specific categories of exec_departure, exec_appointment, or other named event types—it is a servicer transition event best classified as governance_other.
View raw filing on EDGAR →
8-K
Governance Other
confidence 75%
filed 2026-09-01
Item 6.02
This Item 6.02 discloses a change of servicer in a CMBS trust: Greystone Servicing Company LLC sold its special servicing division to C-IV Asset Management LLC, which assumed all duties and liabilities as special servicer for approximately 60 transactions representing $20.7 billion in aggregate principal balance. While the disclosure emphasizes C-IV AM's qualifications, ratings, and continuity of key personnel, the transfer of servicer responsibility for a material portfolio is a governance event affecting the trust's administration and oversight structure. The event is material because it involves a change in the entity responsible for managing special servicing duties on a substantial loan portfolio, which would affect investor confidence in loan administration and recovery prospects.
View raw filing on EDGAR →
8-K
Governance Other
confidence 75%
filed 2026-09-01
Item 6.02
This Item 6.02 discloses a change of servicer in a CMBS securitization: Greystone Servicing Company LLC sold its special servicing division to C-IV Asset Management LLC, which assumed all duties and liabilities as special servicer for the 79 Fifth Avenue Mortgage Loan and approximately 60 transactions representing $20.7 billion in aggregate principal balance as of June 30, 2026. While the filing provides extensive operational and financial details about C-IV AM's qualifications, ratings, and track record, the core event is a change in the party responsible for governance and administration of the securitized loan portfolio. This is material to certificateholders because servicer quality, experience, and financial stability directly affect loan performance and recovery outcomes.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-09-01
Item 6.02
This Item 6.02 discloses a change of servicer in a CMBS trust: Greystone Servicing Company LLC sold its special servicing division to C-IV Asset Management LLC, which assumed all duties and liabilities as special servicer effective September 1, 2026. The transaction involves a substantial portfolio ($20.7 billion in aggregate principal balance across 60 transactions) and represents a material governance change in the trust's administration, though the filing emphasizes continuity of key personnel and C-IV AM's established track record and ratings.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-09-01
Item 6.02
This Item 6.02 discloses a change of servicer in a CMBS trust: Greystone Servicing Company LLC sold its special servicing division to C-IV Asset Management LLC, which assumed all duties and liabilities as special servicer effective September 1, 2026. The transaction involves a portfolio of approximately 60 transactions representing $20.7 billion in aggregate principal balance. While the servicer change is administrative in nature, it is material to certificateholders because the special servicer's competence and financial stability directly affect loan workout outcomes and pool performance.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-09-01
Item 6.02
This Item 6.02 discloses a change of servicer in a mortgage securitization: Greystone Servicing Company LLC sold its special servicing division to C-IV Asset Management LLC, which assumed all duties and liabilities as special servicer for approximately 60 transactions representing $20.7 billion in aggregate principal balance. While the transaction involves operational continuity (key employees transferred, same servicing procedures), the change of servicer is a governance/administrative matter affecting the trust's management structure and oversight. This is material to certificateholders as it affects who manages problem loans and special servicing functions.
View raw filing on EDGAR →
8-K
Governance Other
confidence 75%
filed 2026-09-01
This 8-K discloses a change of servicer under Item 6.02 (Asset-Backed Securities), effective September 1, 2026. Greystone Servicing Company LLC sold substantially all assets of its special servicing division to C-IV Asset Management LLC, which assumed all duties and liabilities as special servicer for the BMARK 2025-V14 securitization and approximately 60 other transactions representing $20.7 billion in aggregate principal balance. While the filing is structured as a servicer change disclosure (governance/administrative), the scale of the transaction—involving transfer of a major servicing portfolio with substantial assets and key personnel—and the detailed disclosure of C-IV AM's qualifications, ratings, and historical performance suggest materiality to investors in the securitization. The event is classified as governance_other rather than a more specific type because no dedicated 8-K item exists for servicer changes in the standard taxonomy, though the disclosure is clearly governance-related and material to the trust's operations.
View raw filing on EDGAR →
8-K
Governance Other
confidence 75%
filed 2026-09-01
Item 6.02
Item 6.02 discloses a change of servicer in a CMBS securitization: Greystone Servicing Company LLC sold its special servicing division to C-IV Asset Management LLC, which assumed all duties and liabilities as special servicer for approximately 60 transactions representing $20.7 billion in aggregate principal balance as of June 30, 2026. This is a material governance/administrative change affecting the management and oversight of the securitized loan portfolio, though it does not fit neatly into the specific event types (it is neither an M&A activity at the registrant level, nor an executive appointment/departure, nor a financial obligation). The change is material because it affects the operational control and servicing of a substantial securitized portfolio.
View raw filing on EDGAR →
8-K
Governance Other
confidence 75%
filed 2026-09-01
Item 6.02
This Item 6.02 discloses a change of servicer in a CMBS securitization: Greystone Servicing Company LLC sold its special servicing division to C-IV Asset Management LLC on September 1, 2026, transferring approximately $20.7 billion in aggregate principal balance across 60 transactions. While the filing emphasizes continuity (key employees transferred, no material changes to policies), the substitution of a new special servicer for a portfolio of this magnitude is a material governance event affecting the administration and oversight of the securitized assets and certificateholder interests.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-09-01
This 8-K discloses a change of servicer under Item 6.02 (Asset-Backed Securities). Effective September 1, 2026, C-IV Asset Management LLC replaced Greystone Servicing Company LLC as special servicer for the FIVE 2023-V1 securitization, acquiring substantially all assets of Greystone's special servicing division and assuming all duties and liabilities. The filing details C-IV AM's qualifications, ratings, and portfolio of approximately $20.7 billion in aggregate principal balance across 60 transactions. While this is a material operational change affecting the administration of mortgage-backed securities, it does not fit the specific named event types (it is not M&A, debt issuance, impairment, etc.) and is best classified as an operational event related to servicer transition.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-09-01
Item 6.02
This disclosure reports a change of special servicer for a mortgage-backed securitization pool under Item 6.02. Greystone Servicing Company LLC sold its special servicing division to C-IV Asset Management LLC, which assumed all duties and liabilities for approximately 60 transactions representing $20.7 billion in aggregate principal balance as of June 30, 2026. While the servicer change itself is administrative, the scale of the portfolio transfer (60 CMBS and other transactions, $20.7 billion in assets) and the operational continuity measures described (key employee retention, compliance procedures, business continuity planning) indicate this is a material operational event affecting the securitization's servicing infrastructure.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-09-01
Item 6.02
This disclosure reports a change of special servicer under Item 6.02, with Greystone Servicing Company LLC's special servicing division assets and duties transferred to C-IV Asset Management LLC effective September 1, 2026. The transaction involves approximately $20.7 billion in aggregate stated principal balance across 60 transactions and 1,928 first-lien mortgage loans. While the new servicer has appropriate ratings (MOR CS2 from Morningstar DBRS, CSS2 from Fitch) and the key personnel transitioned, this represents a material governance change affecting the trust's operational structure and loan servicing oversight, warranting classification as a governance event material to certificateholders.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-09-01
Item 8.01
The filing discloses that C-IV Asset Management LLC will assume the role of special servicer for specific mortgage loans (Sentinel Square II and Centers of High Point) within the FIVE 2023-V1 securitization effective September 1, 2026. This is an operational change in the servicing arrangement for material assets underlying the securitization, affecting how loan administration and REO property servicing will be handled. While not a traditional M&A transaction or governance change, this servicer transition is material to investors in the securitization as it affects the operational management of the underlying collateral.
View raw filing on EDGAR →
8-K
Governance Other
confidence 75%
filed 2026-09-01
Item 6.02
This disclosure reports a change of special servicer effective September 1, 2026, whereby C-IV Asset Management LLC succeeded Greystone Servicing Company LLC under the BMO 2023-5C1 Mortgage Trust's pooling and servicing agreement. While Item 6.02 is the designated item for servicer changes, the event is fundamentally a governance/operational matter involving the substitution of a key service provider responsible for managing approximately $20.7 billion in mortgage assets. The disclosure includes detailed qualifications of the successor servicer, continuity of key personnel, and ratings from Morningstar DBRS, Fitch, and S&P, indicating material importance to certificateholders. This is material because it affects the trust's operational management and the competence of the entity handling special servicing duties.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-09-01
Item 6.02
This Item 6.02 discloses a change of servicer in a mortgage securitization: Greystone Servicing Company LLC sold its special servicing division to C-IV Asset Management LLC, which assumed all duties and liabilities as special servicer for approximately 60 transactions representing $20.7 billion in aggregate principal balance as of June 30, 2026. While the filing provides extensive operational and financial details about C-IV AM's qualifications and track record, the core event is a governance/administrative change in the servicer role. This is material because servicer changes can affect loan performance and certificateholder interests, though it is not a departure or appointment of an executive officer—it is a change in the service provider entity itself.
View raw filing on EDGAR →
8-K
Operational Other
confidence 85%
filed 2026-09-01
Item 6.02
This Item 6.02 discloses a change of servicer in a mortgage securitization: Greystone Servicing Company LLC sold substantially all assets of its special servicing division to C-IV Asset Management LLC on September 1, 2026, with C-IV AM assuming all duties and liabilities as special servicer. The filing includes extensive detail on C-IV AM's qualifications, ratings, portfolio size ($20.7 billion aggregate principal balance), and operational procedures. While this is a servicer transition in a securitized mortgage trust, it is fundamentally an operational/contractual change affecting the administration of the underlying loan portfolio rather than a financial event (debt issuance, impairment, etc.), governance matter (board/executive change), or legal dispute. The materiality stems from the scale of the portfolio transferred and the operational continuity implications for certificateholders.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-09-01
Item 6.02
This Item 6.02 discloses a change of servicer in a mortgage securitization trust: Greystone Servicing Company LLC sold substantially all assets of its special servicing division to C-IV Asset Management LLC, which assumed all duties and liabilities as special servicer effective September 1, 2026. The transaction involves a portfolio of approximately 60 transactions representing $20.7 billion in aggregate principal balance, making it material to certificateholders. While the filing emphasizes continuity (key employees transferred, C-IV AM has strong servicer ratings), the change of servicer is a governance event affecting the trust's administration and oversight structure.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-09-01
Item 8.01
The filing discloses a material extension of the business combination deadline from September 1, 2026 to October 1, 2026, triggered by a $67,500 extension payment from CPRO Korea pursuant to the merger agreement dated May 22, 2026. This represents a material modification to the timing and terms of the contemplated M&A transaction, directly affecting when the company must complete its initial business combination.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-09-01
Item 5.02
The filing discloses both a departure (Mark Klingensmith resigning as CFO and Treasurer effective September 1, 2026) and an appointment (Siddhartha Chowdhury appointed to the same roles on the same date). While both events occur, the appointment is the principal forward-looking disclosure—the Board's action to fill the vacancy with a named successor whose qualifications and background are detailed. The appointment of a CFO is material to investors assessing the company's financial leadership and governance.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-09-01
Item 1.01
Calumet amended its $1.44 billion DOE loan guarantee agreement for Montana Renewables' renewable fuels facility, reducing the guaranteed loan principal to $815.8 million and restructuring the project from a large new-build to a series of smaller modular repurposing projects. The amendment materially restructures project scope, revises key covenants and conditions, and reflects a strategic shift in capital structure and project execution.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-09-01
Item 7.01
The filing discloses completion of a material acquisition of Epsilon Industries for $295 million in cash. The press release explicitly states "Everus Construction Group...announced today that it has completed its acquisition of Epsilon Industries" and describes strategic benefits including expanded geographic reach and enhanced presence in key end markets. This is a completed M&A transaction material to investors' assessment of the company's growth and capital deployment.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-09-01
Item 2.03
TPG Private Equity Opportunities entered into a $125 million revolving credit agreement on August 26, 2026, creating a new direct financial obligation with specified terms, interest rates, covenants, and maturity date.
View raw filing on EDGAR →